InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Immunome Inc.

IMNM Clue Score30
United States Fiscal year ends December CIK 0001472012 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

39
Insider
Date
Role
Action
Shares
Price
Amount
Jack Higgins
11 Sep 2026
Chief Scientific Officer
Sold after exercise
13,200
$25.32
$334.22K
Isaac Barchas
12 Aug 2026
Director
Sold on a plan
11,048
$27.25
$301.06K
Isaac Barchas
11 Aug 2026
Director
Sold on a plan indirect
62,291
$26.23
$1.63M
Isaac Barchas
10 Aug 2026
Director
Sold on a plan indirect
10,125
$26.07
$263.96K
Isaac Barchas
7 Aug 2026
Director
Sold on a plan indirect
15,248
$26.06
$397.36K
Isaac Barchas
6 Aug 2026
Director
Sold on a plan indirect
20,840
$26.06
$543.09K
Kinney Horn
4 Aug 2026
Chief Business Officer
Sold after exercise
90,616
$25.09
$2.27M
Isaac Barchas
7 Jul 2026
Director
Sold on a plan indirect
16,906
$24.20
$409.13K
Kinney Horn
7 Jul 2026
Chief Business Officer
Sold after exercise
1,092
$25.00
$27.30K
Isaac Barchas
6 Jul 2026
Director
Sold on a plan indirect
83,094
$24.11
$2.00M
Isaac Barchas
2 Jul 2026
Director
Sold on a plan indirect
24,335
$23.33
$567.74K
Isaac Barchas
2 Jul 2026
Director
Sold on a plan indirect
75,665
$22.35
$1.69M
Robert Lechleider
2 Jul 2026
Chief Medical Officer
Sold after exercise
16,072
$23.44
$376.73K
Robert Lechleider
2 Jul 2026
Chief Medical Officer
Sold after exercise
16,214
$22.76
$369.03K
Robert Lechleider
2 Jul 2026
Chief Medical Officer
Sold after exercise
22,714
$21.95
$498.57K
Isaac Barchas
30 Jun 2026
Director
Sold on a plan indirect
101,050
$21.12
$2.13M
Robert Lechleider
25 Jun 2026
Chief Medical Officer
Sold after exercise
14,420
$20.66
$297.92K
Robert Lechleider
25 Jun 2026
Chief Medical Officer
Sold after exercise
40,580
$19.56
$793.74K
Max Rosett
15 Jun 2026
Chief Financial Officer
Sold after exercise
60,000
$18.23
$1.09M
Jean Jacques Bienaime
5 Jun 2026
Director
Buy
1,000
$19.27
$19.27K
Jean Jacques Bienaime
5 Jun 2026
Director
Buy
3,500
$19.46
$68.11K
Jean Jacques Bienaime
5 Jun 2026
Director
Buy
6,000
$19.48
$116.88K
Jean Jacques Bienaime
5 Jun 2026
Director
Sell
10,000
$19.41
$194.10K
Jean Jacques Bienaime
5 Jun 2026
Director
Sell
500
$19.44
$9.72K
Jean Jacques Bienaime
15 May 2026
Director
Buy
5,000
$20.70
$103.50K
Max Rosett
2 Apr 2026
Chief Financial Officer
Sold after exercise
1,344
$22.48
$30.21K
Max Rosett
2 Apr 2026
Chief Financial Officer
Sold after exercise
63,656
$21.91
$1.39M
Jack Higgins
2 Apr 2026
Chief Scientific Officer
Sold on a plan
9,438
$21.64
$204.24K
Clay B Siegall
27 Mar 2026
President and CEO
Buy
25,450
$19.67
$500.60K
Philip Wagenheim
23 Mar 2026
Director
Sell
28,200
$20.65
$582.33K
Philip Wagenheim
20 Mar 2026
Director
Sell
36,800
$20.47
$753.30K
Jean Jacques Bienaime
11 Mar 2026
Director
Buy
1,000
$21.55
$21.55K
Jean Jacques Bienaime
10 Mar 2026
Director
Buy
1,000
$22.12
$22.12K
Clay B Siegall
30 Dec 2025
President and CEO
Buy
4,729
$21.15
$100.02K
Isaac Barchas
22 Dec 2025
Director
Sold on a plan indirect
11,251
$22.34
$251.35K
Isaac Barchas
22 Dec 2025
Director
Sold on a plan indirect
371,949
$21.72
$8.08M
Philip Tsai
19 Dec 2025
Chief Technical Officer
Buy
10,000
$20.49
$204.90K
Clay B Siegall
19 Dec 2025
President and CEO
Buy
7,278
$20.48
$149.05K
Clay B Siegall
18 Dec 2025
President and CEO
Buy
46,511
$21.50
$999.99K

What was left out

Form 4 filings counted 37
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 11
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 999,610
History held since 5 Oct 2020